Monday, June 20, 2005 - 20:34

Innate Pharma S.A., a biopharmaceutical company specialized in cancer immuno- therapeutics, today announced the achievement of the first milestone in their collaboration with Novo Nordisk A/S in Denmark.

AttachmentSize
PR in english85.68 KB